CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.4348
-0.0050 (-1.14%)
At close: May 18, 2026, 4:00 PM EDT
0.4039
-0.0309 (-7.11%)
After-hours: May 18, 2026, 5:54 PM EDT
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 39 employees as of December 31, 2025. The number of employees decreased by 18 or -31.58% compared to the previous year.
Employees
39
Change (1Y)
-18
Growth (1Y)
-31.58%
Revenue / Employee
$60,795
Profits / Employee
-$294,590
Market Cap
6.27M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | -18 | -31.58% |
| Dec 31, 2024 | 57 | -18 | -24.00% |
| Dec 31, 2023 | 75 | 2 | 2.74% |
| Dec 31, 2022 | 73 | 7 | 10.61% |
| Dec 31, 2021 | 66 | 14 | 26.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| TransCode Therapeutics | 12 |
| Purple Biotech | 10 |
| XTL Biopharmaceuticals | 10 |
| MetaVia | 8 |
| Acurx Pharmaceuticals | 4 |
| Silo Pharma | 3 |
| Addex Therapeutics | 2 |
| Xenetic Biosciences | 2 |
CLGN News
- 5 weeks ago - CollPlant Issues Letter to Shareholders - PRNewsWire
- 7 weeks ago - CollPlant files to sell 3.3M ordinary shares for holders - TheFly
- 7 weeks ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 7 weeks ago - CollPlant receives non-compliance letter from Nasdaq - TheFly
- 7 weeks ago - CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement - PRNewsWire
- 2 months ago - CollPlant Biotechnologies Launches Redesigned Corporate Website - PRNewsWire
- 2 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS - PRNewsWire
- 2 months ago - CollPlant granted Korean patent for photocurable dermal filler - TheFly